All News

Integra LifeSciences Announces Agreement with Consortium of Focused Orthopedists to Develop a Short Stem and Stemless Shoulder System

PLAINSBORO, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has signed a license and development agreement with Consortium of Focused Orthopedists, LLC (CFO), for a short stem and stemless shoulder system.This is a key addition to Integra’s Extremity Orthopedics portfolio in a fast-growing segment …

Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure

MINNEAPOLIS, Jan. 08, 2019 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced that the Centers for Medicare & Medicaid Services (CMS) has established Healthcare Common Procedure Coding System (HCPCS) codes C9752 and C9753 for the Intracept Procedure effective January 1, 2019. The …

Spineology Provides Duo™ System Commercial and Post-Market Update

January 07, 2019 ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce that over 125 lateral interbody fusion cases have been successfully completed using its unique Duo™ Lumbar Interbody Fusion System. The Duo System features the only implant on the market that combines PEEK, titanium, and graft containment mesh …

VGI Medical Engages Ortho Spine Partners (OSP) to lead US Commercialization Efforts

January 8, 2019 Largo, FL – VGI Medical is dedicated to creating the next generation of spinal implants and procedures to improve the quality of life for its patients. To further advance the adoption of its disruptive technologies, VGI Medical has engaged OSP, formerly known as Ortho Sales Partners, to lead the strategy and execution …

OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018

WARSAW, Ind., Jan. 07, 2019 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2018. Preliminary unaudited fourth quarter 2018 revenue is expected to be in the range of $14.5 million to …

Wright Medical Group N.V. Announces Organizational Changes to Further Drive Long-Term Growth and Profitability

AMSTERDAM, The Netherlands, Jan. 07, 2019 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (NASDAQ: WMGI) today announced organizational changes to further drive the company’s long-term growth and profitability, which support its vision to be the first choice in Extremities and Biologics. Robert Palmisano, president and chief executive officer, stated, “Wright Medical is quickly becoming a …

SI-BONE Reports Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018

SANTA CLARA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System, today announced preliminary unaudited revenue for the fourth quarter and full year 2018. Preliminary and unaudited revenue for fourth quarter 2018 is …

LimaCorporate Heads First 3D Printing Site on Hospital Campus to Address Complex Custom Orthopedic Implants

UDINE, Italy, January 7, 2019 /PRNewswire/ — LimaCorporate (Lima) and the top-ranked orthopedic hospital in the U.S., Hospital for Special Surgery (HSS) announced today they are founding the first additive manufacturing 3D printing facility for custom complex implants in a hospital setting. This innovative collaboration will set the stage to substantially increase the availability and speed of personalized …

DiscGenics Announces that Cell Therapy IDCT has Passed the Initial Safety Review of its First-in-Human Clinical Trial for Degenerative Disc Disease

SALT LAKE CITY, Jan. 7, 2019 /PRNewswire/ — DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that IDCT has passed the initial planned safety review of its Phase I/II trial evaluating the allogeneic, injectable disc cell therapy …

TransEnterix Provides Corporate Update

January 07, 2019 RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today provided a corporate update, including preliminary unaudited revenue for the fourth quarter ended December 31, 2018. “2018 was a significant year for TransEnterix as …

© 2019 MedDeviceJobs.com Powered by Careerleaf
v.3.1.2